Category Prescribing & medicines
Showing: Guidance Include news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
DHSC guidance on medicines supply and distribution
Levemir is being discontinued: switch patients by December 2026
Levemir discontinuation: remaining actions
All Levemir products are being discontinued, and stock may run out before December 2026. Switch remaining patients to a suitable alternative as soon as possible.
QOF obesity indicators OB004 and OB005: NHS England FAQs
NHS England's FAQs on implementing the 2026/27 QOF weight management indicators.
Prescribing for breastfeeding mothers: learning from a rapid review
Always check the BNF for effects on the baby through breast milk, and consider sedative effects on the mother, especially if she co-sleeps.
Proton pump inhibitors in children: new BSol prescribing guidance
BSol IMOC guidance (June 2026): lansoprazole is first-line, using orodispersible tablets for those who can't swallow. Omeprazole liquid is no longer routinely recommended.
Nifedipine MR tablets: shortages across brands and strengths
Tensipine, Dexipress and Adalat LA strengths face supply issues through late 2026. Check the SPS tool for alternatives.
Betnesol-N ear/eye/nose drops unavailable until January 2027
Don't start new patients. Consider the alternatives listed in the SPS Medicines Supply Tool.
Silkis (calcitriol) ointment discontinued 31 August 2026
Don't start new patients. Consider alternative topical vitamin D preparations for plaque psoriasis.